临床误诊误治2024,Vol.37Issue(9) :89-94.DOI:10.3969/j.issn.1002-3429.2024.09.017

谷精草汤化裁方对肝郁化火证高血压病患者血压、肾素活性、血管紧张素Ⅱ及醛固酮的影响

Effects of Gujingcao Modified Formula on Blood Pressure,Renin Activity,Angiotensin Ⅱ and Aldosterone in Patients with Hypertension Induced by Syndrome of Liver Depression Transforming into Fire

赵存方 王强 李惠洲 史佳森 王春亮 毕俊芳 崔晓慧 万鑫苗 申雪娜
临床误诊误治2024,Vol.37Issue(9) :89-94.DOI:10.3969/j.issn.1002-3429.2024.09.017

谷精草汤化裁方对肝郁化火证高血压病患者血压、肾素活性、血管紧张素Ⅱ及醛固酮的影响

Effects of Gujingcao Modified Formula on Blood Pressure,Renin Activity,Angiotensin Ⅱ and Aldosterone in Patients with Hypertension Induced by Syndrome of Liver Depression Transforming into Fire

赵存方 1王强 2李惠洲 3史佳森 2王春亮 2毕俊芳 4崔晓慧 5万鑫苗 6申雪娜4
扫码查看

作者信息

  • 1. 050082 石家庄,联勤保障部队第九八〇医院干部病房
  • 2. 050051 石家庄,石家庄市中医院心三科
  • 3. 050051 石家庄,河北医科大学第三医院麻醉科
  • 4. 050051 石家庄,石家庄市中医院中西医结合科
  • 5. 050011 石家庄,河北省第八人民医院心一科
  • 6. 071066 河北保定,保定市第一医院老年病科
  • 折叠

摘要

目的 观察谷精草化裁方联合厄贝沙坦片治疗对肝郁化火证高血压病患者血压、肾素活性(PRA)、血管紧张素Ⅱ(AngⅡ)及醛固酮(ALD)水平的影响.方法 选取2022 年1 月—2023 年2 月收治的80 例肝郁化火证高血压病,按照随机数字表法分为2 组,对照组40 例予厄贝沙坦片治疗,观察组40 例在对照组基础上加用谷精草化裁方治疗,2 组均治疗8 周.比较2 组治疗前后血压相关指标、中医证候积分和血清PRA、AngⅡ和ALD水平变化,以及治疗期间不良反应情况.结果 治疗8 周后,观察组总有效率为 92.50%(37/40)高于对照组的 75.00(30/40)(P<0.05).治疗后,2 组日间收缩压、日间舒张压、夜间收缩压、夜间舒张压、24h收缩压、24h舒张压、血压负荷均较治疗前下降,且观察组优于对照组(P<0.05).治疗后,观察组各项中医证候积分下降,而对照组仅眩晕、头痛积分降低(P<0.05);治疗后,观察组各项中医证候积分优于对照组(P<0.05).2 组治疗后血清PRA较治疗前升高,AngⅡ和ALD较治疗前降低(P<0.05);观察组治疗后PRA水平高于对照组,AngⅡ和ALD水平低于对照组(P<0.05).2 组不良反应发生率比较差异无统计学意义(P>0.05).结论 谷精草汤化裁方联合厄贝沙坦片治疗肝郁化火证高血压病,可降低患者血压,改善患者临床症状,并能有效抑制AngⅡ和ALD水平,效果显著且安全.

Abstract

Objective To observe the effects of Gujingcao modified formula combined with Irbesartan tablets on blood pressure,plasma renin activity(PRA),angiotensinⅡ(AngⅡ)and aldosterone(ALD)levels in patients with hypertension induced by syndrome of liver depression transforming into fire.Methods From January 2022 to February 2023,80 patients with hypertension induced by syndrome of liver depression transforming into fire were selected and divided into two groups ac-cording to random number table method.Of them,40 patients in the control group were treated with Irbesartan tablets,and 40 patients in the observation group were treated with Gujingcao modified formula on the basis of the control group.Both groups were treated for 8 weeks.Blood pressure-related indexes,TCM syndrome scores,serum levels of PRA,AngⅡand ALD,and adverse reactions during treatment were compared between the two groups before and after treatment.Results At 8 weeks af-ter treatment,the total effective rate of observation group was92.50%(37/40),which was higher than that of control group[75.00(30/40)](P<0.05).After treatment,daytime systolic blood pressure(SBP),daytime diastolic blood pressure(DBP),nighttime SBP,nighttime DBP,24 h SBP,24 h DBP and blood pressure load in the two groups were decreased com-pared with those before treatment,which were better in the observation group than in the control group(P<0.05).After treatment,the scores of all TCM syndromes in the observation group decreased,while the scores of only dizziness and head-ache in the control group decreased(P<0.05).The scores of TCM syndromes in the observation group were better than those in the control group(P<0.05).After treatment,serum PRA in the two groups was higher than that before treatment,while AngⅡ and ALD were lower than those before treatment(P<0.05).After treatment,PRA level in the observation group was higher than that in the control group,while AngⅡ and ALD levels were lower than those in the control group(P<0.05).There was no significant difference in the incidence of adverse reactions between the two groups(P>0.05).Conclusion Gujingcao modified formula combined with Irbesartan tablets can reduce blood pressure,improve clinical symptoms,and effec-tively inhibit AngⅡ and ALD levels in the treatment of hypertension induced by syndrome of liver depression transforming into fire,showing significant effect and good safety.

关键词

高血压/肝郁化火/谷精草汤化裁方/血压/中医证候/肾素活性/血管紧张素Ⅱ/醛固酮

Key words

High blood pressure/Liver depression transforming into fire/Gucaojing modified formula/Blood Pres-sure/TCM syndrome/Renin activity/Angiotensin Ⅱ/Aldosterone

引用本文复制引用

基金项目

河北省中医药局中医药类科研计划(2023)(2023152)

出版年

2024
临床误诊误治
解放军白求恩国际和平医院

临床误诊误治

CSTPCD
影响因子:0.914
ISSN:1002-3429
参考文献量22
段落导航相关论文